Blame China for Your Costly Lobster Roll
Looking for authentic, down-home Maine lobster? Head to China.
The upsurge in demand for lobster in China this year has caused the price of the succulent marine crustacean to shoot up to record highs in the U.S., according to Bloomberg News. Wholesale prices for lobsters have clawed 32 percent higher over the last year.
Lacking a lobster industry itself, China used to rely on Australian imports to meet the demand from an expanding middle class that views lobster as a status symbol. But in 2012, as catches off of Western Australia began dwindling and prices of lobster fell in the Gulf of Maine, China changed its main supplier to the U.S.
Related: McDonald’s Aims for a Classier Crowd with Lobster Rolls
Lobster exports from the East Coast are the main reason for the hike in fish and seafood exports to China in recent years, according to U.S. Department of Agriculture data. Over the past seven months, about 60,000 live North American lobsters a week make the 7,500-mile trek halfway across the world. The lobsters must still be alive by the time they arrive in China or else they lack appeal, so they’re packed in wet newspapers and Styrofoam coolers for a trip that must be made in 18 hours or less, according to Bloomberg.
Another reason for the surge in prices was the bitterly cold winter this year, which slowed the catch in Canada and delayed the summer harvest in Maine.
Holding off on your lobster roll until next summer in the hopes that prices will wane? Don’t count on it. The Chinese middle class is still growing rapidly, and the country already consumes 35 percent of the world’s seafood — a number likely to increase.
Top Reads from The Fiscal Times:
- Born in the USA: 24 Iconic American Foods
- America’s 10 Top Selling Medications
- You’re Richer Than You Think. Really.
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
